TETRABENACINE TREATMENT IN PERSISTING DYSKINESIA CAUSED BY PSYCHOPHARMACA
ERIK BRANDRUP M.D.1
1 Sct. Hans Mental Hospital, Roskilde, Denmark.
In 3 patients suffering from schizophrenia and one patient with arteriosclerotic dementia persisting dyskinetic movements caused by psychopharmaca disappeared almost or completely after treatment with tetrabenacine (Nitoman®). The schizophrenics received a daily dose of 75 mg., whereas it was necessary to give the patient with dementia 150-300 mg. per day in order to obtain a satisfactory effect. This patient responded by developing a certain degree of drowsiness, while no side effects were observed in the other cases.
